Dolby Laboratories (NYSE:DLB) is set to post its quarterly earnings results after the market closes on Wednesday, October 24th. Analysts expect Dolby Laboratories to post earnings of $0.29 per share for the quarter.
Dolby Laboratories (NYSE:DLB) last released its earnings results on Wednesday, July 25th. The electronics maker reported $0.92 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.69 by $0.23. The firm had revenue of $317.45 million during the quarter, compared to analyst estimates of $317.65 million. Dolby Laboratories had a net margin of 8.18% and a return on equity of 12.95%. The business’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.73 EPS. On average, analysts expect Dolby Laboratories to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Dolby Laboratories stock opened at $69.00 on Tuesday. The firm has a market cap of $7.13 billion, a price-to-earnings ratio of 31.36, a PEG ratio of 2.17 and a beta of 0.78. Dolby Laboratories has a fifty-two week low of $56.50 and a fifty-two week high of $74.29.
In other news, CFO Lewis Chew sold 17,000 shares of the company’s stock in a transaction dated Tuesday, August 7th. The shares were sold at an average price of $65.47, for a total transaction of $1,112,990.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Dagmar Dolby sold 22,642 shares of the company’s stock in a transaction dated Tuesday, September 4th. The shares were sold at an average price of $70.07, for a total transaction of $1,586,524.94. The disclosure for this sale can be found here. Insiders have sold 99,642 shares of company stock valued at $6,816,715 in the last ninety days. 43.74% of the stock is owned by company insiders.
A number of research analysts have weighed in on the stock. R. F. Lafferty cut their target price on shares of Dolby Laboratories from $81.00 to $80.00 and set a “buy” rating for the company in a research report on Monday. Zacks Investment Research lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Tuesday, June 26th. ValuEngine lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, July 11th. B. Riley upped their price objective on shares of Dolby Laboratories from $61.00 to $69.00 and gave the company a “neutral” rating in a research report on Thursday, July 26th. Finally, Barrington Research reaffirmed a “buy” rating and set a $78.00 price objective on shares of Dolby Laboratories in a research report on Thursday, July 26th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Dolby Laboratories presently has a consensus rating of “Buy” and a consensus price target of $74.00.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.
Featured Article: How Important is Technical Analysis of Stocks
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.